Pomdoctor’s Online Hospital Revenue Jumps 82%—Margin Pressures Remain Despite IPO Success
Market Chameleon (Thu, 4-Dec 6:50 AM ET)
POMDOCTOR LIMITED Announces First Half of Fiscal 2025 Unaudited Financial Results
PRNewswire (Wed, 3-Dec 4:15 PM ET)
POMDOCTOR LIMITED Announces Full Exercise and Closing of Underwriter's Over-Allotment Option
PRNewswire (Fri, 10-Oct 5:15 PM ET)
POMDOCTOR LIMITED Announces Closing of Initial Public Offering
PRNewswire (Thu, 9-Oct 4:05 PM ET)
POMDOCTOR LIMITED Announces Pricing of Initial Public Offering
PRNewswire (Wed, 8-Oct 8:01 AM ET)
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.
Pomdoctor Limited - American Depositary Shares trades on the NASDAQ stock market under the symbol POM.
As of December 29, 2025, POM stock price declined to $0.35 with 512,252 million shares trading.
POM has a market cap of $41.17 million. This is considered a Sub-Micro Cap stock.
POM support price is $.31 and resistance is $.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that POM shares will trade within this expected range on the day.
